Patricia Khashayar

Prof. Dr. Patricia Khashayar

International Institute of Biosensing, University of Minnesota - Twin Cities, Minneapolis, Minnesota, USA
orcid
Director, International Institute of Biosensing

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Renal Failure
Verified
Journal Article
Open access
MKMohammad Reza Khajavi
Mohammad Reza Khajavi
FEFarhad Etezadi
Farhad Etezadi
RMReza Shariat Moharari
Reza Shariat Moharari
FIFarsad Imani
Farsad Imani
AMAli Pasha Meysamie
Ali Pasha Meysamie
ANAtabak Najafi
Atabak Najafi
Aim. We hypothesized that normal saline (NS) may have more deleterious effects compared with lactated ringer (LR) in kidney transplant recipients because of the higher risk of acidosis and higher levels of serum potassium. Thus, the aim of this study was to determine the safety of LR if used during a renal transplant. Methods. Adults undergoing kidney transplantations were enrolled in a double-blinded randomized prospective clinical trial. They were divided into two groups in order to receive NS and LR infusion as intraoperative IV fluid replacement therapy. Results. There was a significant difference in the serum potassium level (p = .000) and the PH (p = .007) between the two groups at the end of transplantations. Two patients in the LR group lost their kidneys due to vascular graft thrombosis. In other words, hyperkalemia and acidosis occurred more frequently in the NS group while thrombotic events may be of concern in the LR group. Conclusion. Compared with NS, LR infusion may lead to a lower serum potassium level and a lower risk of acidosis, while there is major concern of the hypercoagulable state in these patients.

7 February 2017 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
OTOzra Tabatabaei-Malazy
Ozra Tabatabaei-Malazy
PSPooneh Salari
Pooneh Salari
PKPatricia Khashayar
Patricia Khashayar
BLBagher Larijani
Bagher Larijani
Prevalence of osteoporosis is increasing both in developed and developing countries. Due to rapid growth in the burden and cost of osteoporosis, worldwide,

1 January 2009 in Renal Failure
Verified
Journal Article
Closed access
EREffat Razeghi
Effat Razeghi
DEDelaram Eskandari
Delaram Eskandari
MGMohammad Reza Ganji
Mohammad Reza Ganji
AMAli Pasha Meysamie
Ali Pasha Meysamie
MTMansooreh Togha
Mansooreh Togha
PKPatricia Khashayar
Patricia Khashayar
Pruritus is a common and bothersome problem in 30-50% of hemodialysis patients. The aim of this study was to determine the effect of gabapentin, 100 mg/three times a week (after each hemodialysis session), on uremic pruritus. Patients older than 18 years who had undergone hemodialysis for more than three months were enrolled in this double-blind clinical trial. They had experienced pruritus refractory to antihistamines for at least two weeks. The patients were assigned to receive gabapentin 100 mg following hemodialysis for a period of four weeks, and after a washout week, they received the placebo for another four weeks. They were asked to evaluate the severity of their pruritus using a visual analogue scale (VAS). The reduction of pruritus >or= 50% was accepted as the response. The mean pruritus score reached 6.44 +/- 8.4 (p < 0.0001), 15 +/- 11.2 (p < 0.001), and 81.11 +/- 11.07 (p < 0.001) during gabapentin, washout, and placebo periods, respectively. No significant correlation was found between age, sex, duration of dialysis, underlying diseases, and systolic and diastolic blood pressures and the gabapentin effect. Gabapentin is an effective agent in treating uremic pruritus.

1 January 2009 in Surgical Neurology
Verified
Journal Article
Closed access
SSSeyed Hossein Sadrolsadat
Seyed Hossein Sadrolsadat
AMAli Reza Mahdavi
Ali Reza Mahdavi
RMReza Shariat Moharari
Reza Shariat Moharari
MKMohammad Reza Khajavi
Mohammad Reza Khajavi
PKPatricia Khashayar
Patricia Khashayar
AAAbbas Amirjamshidi
Abbas Amirjamshidi

22 December 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
Mostafa AzimzadehMostafa Azimzadeh
Mostafa Azimzadeh
PKPatricia Khashayar
Patricia Khashayar
Meitham AmerehMeitham Amereh
Meitham Amereh
Nishat TasnimNishat Tasnim
Nishat Tasnim
Mina HoorfarMina Hoorfar
Mina Hoorfar
Mohsen AkbariMohsen Akbari
Mohsen Akbari
Oxygen (O2) quantification is essential for assessing cell metabolism, and its consumption in cell culture is an important indicator of cell viability. Recent advances in microfluidics have made O2 sensing a crucial feature for organ-on-chip (OOC) devices for various biomedical applications. OOC O2 sensors can be categorized, based on their transducer type, into two main groups, optical and electrochemical. In this review, we provide an overview of on-chip O2 sensors integrated with the OOC devices and evaluate their advantages and disadvantages. Recent innovations in optical O2 sensors integrated with OOCs are discussed in four main categories: (i) basic luminescence-based sensors; (ii) microparticle-based sensors; (iii) nano-enabled sensors; and (iv) commercial probes and portable devices. Furthermore, we discuss recent advancements in electrochemical sensors in five main categories: (i) novel configurations in Clark-type sensors; (ii) novel materials (e.g., polymers, O2 scavenging and passivation materials); (iii) nano-enabled electrochemical sensors; (iv) novel designs and fabrication techniques; and (v) commercial and portable electrochemical readouts. Together, this review provides a comprehensive overview of the current advances in the design, fabrication and application of optical and electrochemical O2 sensors.

6 September 2023 in Bioelectrochemistry
Verified
Journal Article
Closed access
ESEmadoddin Amin Sadrabadi
Emadoddin Amin Sadrabadi
ABAli Benvidi
Ali Benvidi
MAMostafa Azimzadeh
Mostafa Azimzadeh
LALeila Asgharnejad
Leila Asgharnejad
ADAmin Shiralizadeh Dezfuli
Amin Shiralizadeh Dezfuli
PKPatricia Khashayar
Patricia Khashayar